PipelinePharma Logo

dimenhydrinate Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Philippines
GMP approvals
FDA
Manufacturer #21161

Established in 1976, this Manufacturer is a leading CTD dossier owner and manufacturer based in San Pedro, Laguna, Philippines, employing between 101 to 1,000 professionals. As a GMP manufacturer, it operates a 14-building complex equipped with state-of-the-art facilities, including mixers, compression machines, compounding tanks, dryers, encapsulation machines, and packaging equipment. The Manufacturer's diverse product portfolio encompasses pharmaceuticals, healthcare products, cosmetics, veterinary and agricultural products, as well as home care items. As a CTD dossier owner and manufacturer, it ensures compliance with stringent regulatory standards. Committed to excellence, this GMP manufacturer continues to expand its presence in both domestic and international markets.

 

Manufacturer usually replies in 8 days

Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection. Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.